A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
一项评估 Alpelisib 联合西妥昔单抗治疗复发或转移性头颈部鳞状细胞癌患者的 1b/2 期研究
期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-023-00997-z
Razak, Albiruni R Abdul; Wang, Hung-Ming; Chang, Jang-Yang; Ahn, Myung-Ju; Munster, Pamela; Blumenschein, George Jr; Solomon, Benjamin; Lim, Darren Wan-Teck; Hong, Ruey-Long; Pfister, David; Saba, Nabil F; Lee, Se-Hoon; van Herpen, Carla; Quadt, Cornelia; Bootle, Douglas; Blumenstein, Lars; Demanse, David; Delord, Jean-Pierre
